Clinical Trials Browser

tosedostat × Tumor-Agnostic × Clear all

NCT00737555 2012-02-15

A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours

Phase 1 Completed

Neoplasms

NCT00692354 2010-08-06

Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours

Phase 1 Completed

Neoplasms